Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Industry Update: The latest developments in therapeutic delivery.
Relationship between Damage to the Cerebellar Peduncles and Clinical Disability in Multiple Sclerosis.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Fulminant Demyelinating Diseases of the Central Nervous System.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
A Helminth Protease Inhibitor Modulates the Lipopolysaccharide-Induced Proinflammatory Phenotype of Microglia in vitro.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
Dermatoglyphic features in patients with multiple sclerosis.
Time-Lapse Imaging of Glial-Axonal Interactions.
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
NMDA receptor antibodies associated with distinct white matter syndromes.
Pages
« first
‹ previous
…
378
379
380
381
382
383
384
385
386
…
next ›
last »